1. Home
  2. LYRA vs ASTC Comparison

LYRA vs ASTC Comparison

Compare LYRA & ASTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYRA
  • ASTC
  • Stock Information
  • Founded
  • LYRA 2005
  • ASTC 1984
  • Country
  • LYRA United States
  • ASTC United States
  • Employees
  • LYRA N/A
  • ASTC N/A
  • Industry
  • LYRA Medical/Dental Instruments
  • ASTC Biotechnology: Laboratory Analytical Instruments
  • Sector
  • LYRA Health Care
  • ASTC Industrials
  • Exchange
  • LYRA Nasdaq
  • ASTC Nasdaq
  • Market Cap
  • LYRA 11.8M
  • ASTC 11.0M
  • IPO Year
  • LYRA 2020
  • ASTC 1995
  • Fundamental
  • Price
  • LYRA $0.12
  • ASTC $6.27
  • Analyst Decision
  • LYRA Hold
  • ASTC
  • Analyst Count
  • LYRA 4
  • ASTC 0
  • Target Price
  • LYRA $1.25
  • ASTC N/A
  • AVG Volume (30 Days)
  • LYRA 828.8K
  • ASTC 2.2K
  • Earning Date
  • LYRA 03-13-2025
  • ASTC 05-12-2025
  • Dividend Yield
  • LYRA N/A
  • ASTC N/A
  • EPS Growth
  • LYRA N/A
  • ASTC N/A
  • EPS
  • LYRA N/A
  • ASTC N/A
  • Revenue
  • LYRA $1,534,000.00
  • ASTC $419,000.00
  • Revenue This Year
  • LYRA N/A
  • ASTC N/A
  • Revenue Next Year
  • LYRA $519.89
  • ASTC N/A
  • P/E Ratio
  • LYRA N/A
  • ASTC N/A
  • Revenue Growth
  • LYRA N/A
  • ASTC N/A
  • 52 Week Low
  • LYRA $0.12
  • ASTC $6.04
  • 52 Week High
  • LYRA $6.29
  • ASTC $12.29
  • Technical
  • Relative Strength Index (RSI)
  • LYRA 23.27
  • ASTC 47.60
  • Support Level
  • LYRA $0.14
  • ASTC $6.19
  • Resistance Level
  • LYRA $0.20
  • ASTC $6.53
  • Average True Range (ATR)
  • LYRA 0.01
  • ASTC 0.15
  • MACD
  • LYRA -0.00
  • ASTC 0.01
  • Stochastic Oscillator
  • LYRA 1.05
  • ASTC 52.78

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About ASTC Astrotech Corporation (DE)

Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.

Share on Social Networks: